| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |